Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04644419 · ClinicalTrials.gov registry record
Chemotherapy-related Cognitive Impairment and Acute Leukemia
A clinical trial, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- 25
- Enrollment target
NCT04644419 is a clinical trial that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 25 participants.
The verdict
NCT04644419 has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
This is an ancillary study of an intervention study (NCT04570709). The parent study is a single institution, feasibility trial of 20 (10 control and 10 intervention) patients with the primary objective of assessing feasibility, acceptability, and change in pre and post measures of symptoms, function, and quality of life by administering the Palliative and Collaborative Care InTervention (PACT). We will further assess cognitive function in the patients who participate in the control of the parent study.
Interventions
- OTHER none (observational study)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2020-11-03 |
| Est. Completion | 2023-05-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04644419
The ClinicalTrials.gov registry entry for NCT04644419 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which none (observational study) is the first listed.
NCT04644419 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04644419 about?
NCT04644419 is a clinical study titled "Chemotherapy-related Cognitive Impairment and Acute Leukemia". This is an ancillary study of an intervention study (NCT04570709). The parent study is a single institution, feasibility trial of 20 (10 control and 10 intervention) patients with the primary objective of assessing feasibility, acceptability, and change in pre and post measures of symptoms, function...
What is the current status of trial NCT04644419?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2020-11-03. Estimated completion is 2023-05-03.
What interventions are being tested in trial NCT04644419?
The interventions under investigation include: none (observational study) (OTHER).
Who is sponsoring clinical trial NCT04644419?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.